Commentary: Toward Resolving Some Dilemmas Concerning Psychiatric Advance Directives (original) (raw)

2006, Journal of the American Academy of Psychiatry and the Law Online

AI-generated Abstract

The commentary discusses the challenges associated with psychiatric advance directives (PADs) and emphasizes the legal and ethical dilemmas regarding their enforceability in the context of civil commitment legislation. It introduces the concept of Joint Crisis Plans (JCPs) as an alternative to PADs, highlighting their effectiveness in reducing compulsory hospital admissions and empowering patients. The findings suggest that collaborative agreements between patients and service providers can lead to better treatment outcomes, advocating for the adoption of JCPs in various jurisdictions.

Sign up for access to the world's latest research.

checkGet notified about relevant papers

checkSave papers to use in your research

checkJoin the discussion with peers

checkTrack your impact

Who Decides?: Consent, Capacity and Medical Treatment

2021

It is a fundamental ethical and legal requirement that consent should be <br> obtained before providing medical treatment. Despite this, basic legal <br> questions arise regarding consent for those who lack decision-making capacity to consent to treatment. Many of these questions will be addressed when the Assisted Decision-Making (Capacity) Act 2015 (the 2015 Act) comes fully into force. This chapter identifies the impact of the 2015 Act on consent to treatment; the questions which will remain and the matters which still need <br> to be addressed to provide clarity. First, however, we look at the current Irish <br> law (the position prior to the 2015 Act coming into force).

The ill-informed: Consent to medical treatment and the therapeutic exception. 2017 46(2) Common Law World Review 140-168

Affirming the doctrine of informed consent, the UK Supreme Court in Montgomery v Lanarkshire HB belatedly followed the Australian decision of Rogers v Whitaker, decoupling the duty to inform patients about the material risks of medical treatment from Bolam. The underlying commitment to patient autonomy coincides with a wider body of medical law that protects the right of capacitous adult patients to make treatment decisions, even if others consider those decisions bizarre and even if they will cause the patient serious harm. It is seemingly anomalous, therefore, that the Supreme Court in Montgomery referred to a 'therapeutic exception' (TE), as this suggests an underlying paternalistic approach. Contrary to this view, international examples suggest that a TE does not necessarily conflict with commitment to patient autonomy. In some countries, the exception mitigates the effects of a broadly objective test of materiality by enabling clinicians in exceptional circumstances to protect the autonomy interests of the particular patient. In others, it protects those incapable of an autonomous decision from harm. In England and Wales, however, alternative mechanisms can be interpreted to protect such patients from harm. On this basis, it is argued that the TE is obfuscatory, unnecessary and unjustified.

Psychiatric advance decisions – an opportunity missed

International Journal of Mental Health and Capacity Law, 2014

After a very long gestation the Mental Capacity Bill 1 (the Bill) was published earlier this year. Among its proposals was the incorporation into statute of advance decisions. These are devices whereby a person, while retaining capacity, can make certain decisions regarding their future treatment for such a time as they have lost capacity and so are unable to make legally binding decisions about their own treatment. As the Bill is phrased, advance decisions (ADs) only permit a person to refuse treatment. There is no provision for that person to use ADs to express a positive preference for particular forms of treatment. It will be argued this represents a missed opportunity to allow patients and clinicians to engage in a more constructive approach to treatment planning. Experience from the USA demonstrates psychiatric advance directives (PADs) have a role to play in engaging psychiatric patients and promoting adherence to their treatment plans. This paper will only address the use of AD in relation to mental health treatment, although it is recognised they have an application far wider than this, including decisions regarding life-sustaining treatment. * Consultant Forensic Psychiatrist who has worked both at Broadmoor (high secure) Hospital and, currently in a medium secure psychiatric unit. He has published in the areas of psychiatric assessment schemes in magistrates courts, forensic psychiatric service provision and mental health legislation.

The right to refuse treatment: a broad view

The Bulletin of the American Academy of Psychiatry and the Law

Psychiatry shares with other professions certain common characteristics. Sociologically, a profession is defined as an occupation based on a unique theoretical and scientific body of knowledge, whose practitioners have a service orientation, and autonomy in the performance of their work (Hughes, 1965). In addition to these three core characteristics, psychiatry is beginning to experience a trend which has been occurring in other professions. This trend has been referred to as "the revolt of client" (Haug and Sussman, 1969) and is surfacing in psychiatry under the label of the patient's right to refuse treatment. In this presentation, we wish to sketch out some of the major issues surrounding this complex question of the right of mental patients to refuse treatment.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.